Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-26 @ 11:11 PM
Ignite Modification Date:
2025-12-26 @ 11:11 PM
NCT ID:
NCT03095612
Group ID:
EG002
Title:
Dose Escalation:Selinexor 100mg + Docetaxel 75mg/m2
Description:
Selinexor will be administered once weekly starting one week before chemotherapy initiation in combination with docetaxel. Docetaxel will be given once every 3 weeks. Treatment will be administered in 21-day cycles. Selinexor dose escalation: 60, 80, 100 mg once weekly. Docetaxel 75 mg/m2 IV, 60 every 3 weeks.
Selinexor: Selinexor once weekly oral or twice weekly oral
Docetaxel: Docetaxel once every 3 weeks (75 mg/m2 IV)
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
0
Serious Number At Risk:
0
Other Number Affected:
0
Other Number At Risk:
0
Study:
NCT03095612
Results Section:
NCT03095612
Adverse Events Module:
NCT03095612